Valneva Initiates Rolling Submission of FDA Biologics License Application for its Single-Shot Chikungunya Vaccine Candidate Read more
Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults Read more
bluebird bio Announces FDA Approval of ZYNTEGLO, the First Gene Therapy for People with Beta-Thalassemia Who Require Regular Red Blood Cell Transfusions Read more
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware Read more
RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies Read more
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma Read more
Respiratory Monitoring & AI Technologies – hear more at the Biosensors for Medical Wearables Conference Read more
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Survival with RADICAVA (edaravone) Read more